ResMed Inc. (NYSE:RMD) Declares Quarterly Dividend of $0.60

ResMed Inc. (NYSE:RMD) declared a quarterly dividend on Thursday, January 29th. Shareholders of record on Thursday, February 12th will be paid a dividend of 0.60 per share by the medical equipment provider on Thursday, March 19th. This represents a c) dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Thursday, February 12th.

ResMed has increased its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 13 consecutive years. ResMed has a dividend payout ratio of 22.7% meaning its dividend is sufficiently covered by earnings. Analysts expect ResMed to earn $10.36 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 23.2%.

ResMed Stock Performance

Shares of RMD stock traded down $6.78 on Friday, hitting $250.83. The company’s stock had a trading volume of 370,752 shares, compared to its average volume of 914,647. ResMed has a fifty-two week low of $199.92 and a fifty-two week high of $293.81. The company has a market capitalization of $36.61 billion, a PE ratio of 25.60, a PEG ratio of 1.73 and a beta of 0.88. The stock’s 50 day moving average is $250.90 and its 200-day moving average is $263.20. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.13 and a current ratio of 2.89.

ResMed (NYSE:RMD) last announced its earnings results on Thursday, January 29th. The medical equipment provider reported $2.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.68 by $0.13. ResMed had a net margin of 27.35% and a return on equity of 25.45%. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the prior year, the business posted $2.43 EPS. The business’s revenue was up 11.0% compared to the same quarter last year. Equities research analysts expect that ResMed will post 9.47 earnings per share for the current fiscal year.

About ResMed

ResMed (NYSE: RMD) is a global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions. Founded in 1989, the company is headquartered in San Diego, California, and develops, manufactures and distributes a range of devices and software used by patients, clinicians and providers worldwide.

ResMed’s product portfolio centers on noninvasive ventilation and sleep therapy equipment, including continuous positive airway pressure (CPAP) and bilevel devices, masks and related accessories for the treatment of obstructive sleep apnea and other respiratory disorders.